For a More Effective Way to Improve the Patient Experience
When you step into your doctor’s office for an appointment, your doctor treats you personally. The doctor considers your age, your medical history, your lifestyle, and many more pieces of data that make you unique. The reason why is obvious: Personalized healthcare is better healthcare.
But when it comes to other aspects of healthcare, like medical devices or drug therapies, personalization has long been out of reach. Today, that is changing. The life sciences industry can now see unique patient populations at a deeper, more meaningful level. This means it can develop targeted therapies to help those populations. We hope the stories of personalized healthcare breakthroughs we’ve gathered here will inspire you to create the next one.
Why are the most innovative life sciences companies using 3D printing? Because this revolutionary technology enables them to bridge the gap between digital and physical environments. Looking for a more specific answer? We will give you five. Here are 5 Reasons Why Innovative Life Sciences Companies Need to Master 3D Printing.
Most of the major breakthroughs in medical history have been “macro” solutions to large-scale problems — the development of antibiotics to combat communicable disease, for example. But many of today’s breakthroughs are coming at the “micro” level, with highly specialized solutions keyed to the needs of certain populations and, in some cases, even individual patients. In our eBook, A Closer Look at Personalized Health, you will learn how researchers, practitioners, and medical device companies are using 3D design, simulation, and additive manufacturing technologies to improve the patient experience in healthcare by personalizing it.
Improve healthcare and the patient experience with unified 3d design, simulation and additive manufacturing technologies
Stents save lives. Deployed in blocked arteries, they restore the passage of blood flow. The more reliable and effective medical device companies can make devices like stents, the better healthcare outcomes will be. Today, realistic simulation is playing a key role in medical device manufacturing companies’ efforts to enhance and optimize the performance of their devices. In our eBook, Transforming the Development of Medical Devices With Realistic Simulation, learn how Dassault Systèmes customers are leveraging advances in realistic simulation to accelerate the pace of cardiovascular medical device innovation.
Read our Economist Intelligence Unit study, sponsored by MEDIDATA, where we explore the current state of patient centricity within clinical trials and how this is likely to evolve as researchers move from patient centric initiatives to true co-creation with patients.
Up to 1.5 million people in the U.S. suffer from aortic valve disease. Some of those people are too old or too ill to undergo traditional open-heart surgery. For this targeted patient population, a less invasive approach called transcatheter aortic valve implantation (TAVI) can be the answer. FEops, a life sciences company based in Belgium, set out to make TAVI procedures safer and more effective by enabling simulations tailored to each individual patient’s anatomy.
FEops uses simulation solutions from Dassault Systèmes to help clinicians and medical-device manufacturers customize patient treatment
We know where the strength of others lies as well, which is why we are using Dassault Systèmes software. It’s the best there is and we want to work with the best technologies out there and link them up to our own unique expertise.
Learn more about how our Industry Solutions can help you achieve your professional ambitions and business objectives.